Rapid Dose Therapeutics Corp.

Rapid Dose Therapeutics Corp.

RDTCF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$7.88M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Rapid Dose Therapeutics Corp.Rapid Dose Therapeutics Corp.-4.3-38%--0.7

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$7.88 Million
Enterprise Value$13.25 Million
Earnings per Share$-0.03
Beta-4.25
Outstanding Shares136,036,016

Return

Return on Equity38.33%ROE
Return on Assets-107.33%
Return on Invested Capital29.67%

Valuation & Multiples

P/E Ratio-4.26P/E Ratio
PEG124.92PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.06Price to Book Ratio
Enterprise Value to Revenue6.26
Enterprise Value to EBIT-7.07
Enterprise Value to Net Income-5
Total Debt to Enterprise0.41
Debt to Equity-0.66Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Rapid Dose Therapeutics Corp.

12 employees
CEO: Mark Andrew Upsdell

Rapid Dose Therapeutics Corp., headquartered in Burlington, Canada, is a life sciences enterprise dedicated to developing advanced drug delivery technologies aimed at improving health results and individuals' quality of life. The company...